Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

All for Statins and Statins for All; An Update

Author(s): Aris P. Agouridis, Moses S. Elisaf, Devaki R. Nair and Dimitri P. Mikhailidis

Volume 22, Issue 1, 2016

Page: [18 - 27] Pages: 10

DOI: 10.2174/1381612822666151109111511

Price: $65

Abstract

Statins exert beneficial effects on cardiovascular [CV] outcomes as well as on inflammation and oxidative stress. The widespread use of statins for both primary and secondary CV disease prevention is based on the evidence from large randomized controlled trials. The benefits of statin treatment outweigh any harm in high risk patients. In this narrative review, we provide an update on several aspects of statin treatment based on the most recent evidence in this field.

Keywords: Statin, cardiovascular disease, cardiovascular risk factors, prevention.


Rights & Permissions Print Export Cite as
© 2024 Bentham Science Publishers | Privacy Policy